Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;236(9):6168-6189.
doi: 10.1002/jcp.30303. Epub 2021 Feb 9.

Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer

Affiliations
Review

Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer

Hamid Aria et al. J Cell Physiol. 2021 Sep.

Abstract

A recently proposed term "immunometabolism" points to the functional intracellular metabolic changes that occur within different immune cells. Recent findings suggest that immune responses can be determined by the metabolic status of immune cells and metabolic reprogramming is an important feature of immune cell activation. Metabolic reprogramming is also well known for cancer cells and has been suggested as a major sign of cancer progression. Metabolic reprogramming of immune cells is also seen in the tumor microenvironment. In the past decade, immunometabolism has progressively become an extraordinarily vibrant and productive area of study in immunology because of its importance for immunotherapy. Understanding the immunometabolic situation of T cells and other immune cells along with the metabolic behavior of cancer cells can help us design new therapeutic approaches against cancers. Here, we have the aim to review the cutting-edge findings on the immunometabolic situation in immune and tumor cells. We discuss new findings on signaling pathways during metabolic reprogramming, its regulation, and the participation of reactive oxygen species in these processes.

Keywords: T cells; immunometabolism; metabolic reprogramming; reactive oxygen species; tumor cells.

PubMed Disclaimer

References

REFERENCES

    1. Abdou, Y. , Pandey, M. , Sarma, M. , Shah, S. , Baron, J. , & Ernstoff, M. S. (2020). Mechanism-based treatment of cancer with immune checkpoint inhibitor therapies. British Journal of Clinical Pharmacology, 86, 1690-1702.
    1. Adams, T. A. , Vail, P. J. , Ruiz, A. , Mollaee, M. , McCue, P. A. , Knudsen, E. S. , & Witkiewicz, A. K. (2018). Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer. Modern Pathology, 31(2), 288-298.
    1. Al-Khami, A. A. , Zheng, L. , Del Valle, L. , Hossain, F. , Wyczechowska, D. , Zabaleta, J. , Sanchez, M. D. , Dean, M. J. , Rodriguez, P. C. , & Ochoa, A. C. (2017). Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology, 6(10), e1344804.
    1. Al-Khami, A. A. , Rodriguez, P. C. , & Ochoa, A. C. (2017). Energy metabolic pathways control the fate and function of myeloid immune cells. Journal of Leukocyte Biology, 102(2), 369-380.
    1. Amelio, I. , Cutruzzolá, F. , Antonov, A. , Agostini, M. , & Melino, G. (2014). Serine and glycine metabolism in cancer. Trends in Biochemical Sciences, 39(4), 191-198.

LinkOut - more resources